PIN48 COMPARATIVE COST-EFFICACY ANALYSIS OF DARUNAVIR/R AND OTHER RITONAVIR-BOOSTED PROTEASE INHIBITORS FOR FIRST-LINE TREATMENT OF HIV-I INFECTION IN GERMANY

Oct 1, 2009, 00:00
10.1016/S1098-3015(10)75106-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)75106-8/fulltext
Title : PIN48 COMPARATIVE COST-EFFICACY ANALYSIS OF DARUNAVIR/R AND OTHER RITONAVIR-BOOSTED PROTEASE INHIBITORS FOR FIRST-LINE TREATMENT OF HIV-I INFECTION IN GERMANY
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)75106-8&doi=10.1016/S1098-3015(10)75106-8
First page :
Section Title :
Open access? : No
Section Order : 1031
Categories :
Tags :
Regions :
ViH Article Tags :